{"brief_title": "CAFE Comparison of Atypicals in First Episode of Psychosis", "brief_summary": "The purpose of this study is to compare the effectiveness, tolerability, and efficacy of the currently available atypical antipsychotic drugs olanzapine (2.5-20 mg/day), quetiapine (100-800 mg/day) and risperidone (0.5-4 mg/day) in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder who are experiencing their first psychotic episode.", "condition": "Mental Disorders", "intervention_type": "Drug", "intervention_name": "Olanzapine, risperidone", "criteria": "Inclusion Criteria: - Patients must meet criteria for schizophreniform disorder, schizophrenia, or schizoaffective disorder with psychotic symptoms lasting 1-60 months - Psychotic symptoms must have persisted at least one month, and not more thn 5 years (60 months) - Patients must have no previous history of drug treatment (greater than a total of 16 weeks) with antipsychotics Exclusion Criteria: - Patients with history of psychotic disorder with recovery period of at least 3 months - Female patients who are pregnant or nursing - Patients with a known history of mental retardation", "gender": "All", "minimum_age": "16 Years", "maximum_age": "40 Years", "healthy_volunteers": "No", "id": "NCT00034892.xml"}